Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Greenberg

Showing results (671-680 of 696) with videos related to

Pageof 70
Sort By:
JAMA Internal Medicine|February 10, 2016
Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical TrialMichael K Ong, Patrick S Romano, Sarah Edgington, et al.
Plos One|March 3, 2022
Clinically adjudicated deceased donor acute kidney injury and graft outcomesSherry G Mansour, Nadeen Khoury, Ravi Kodali, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Physical Review Letters|December 31, 2008
Experimental constraints on a dark matter origin for the DAMA annual modulation effectC E Aalseth, P S Barbeau, D G Cerdeño, et al.
Nature|September 21, 2023
A multi-stem cell basis for craniosynostosis and calvarial mineralizationSeoyeon Bok, Alisha R Yallowitz, Jun Sun, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American Society of Nephrology : JASN|October 30, 2020
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) StudySarah J Schrauben, Haochang Shou, Xiaoming Zhang, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
BMC Neurology|April 10, 2021
Blood flow response to orthostatic challenge identifies signatures of the failure of static cerebral autoregulation in patients with cerebrovascular diseaseClara Gregori-Pla, Rickson C Mesquita, Christopher G Favilla, et al.
Pageof 70

Showing results (671-680 of 696) with videos related to

Sort By:
Pageof 70
JAMA Internal Medicine|February 10, 2016
Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical TrialMichael K Ong, Patrick S Romano, Sarah Edgington, et al.
Plos One|March 3, 2022
Clinically adjudicated deceased donor acute kidney injury and graft outcomesSherry G Mansour, Nadeen Khoury, Ravi Kodali, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Physical Review Letters|December 31, 2008
Experimental constraints on a dark matter origin for the DAMA annual modulation effectC E Aalseth, P S Barbeau, D G Cerdeño, et al.
Nature|September 21, 2023
A multi-stem cell basis for craniosynostosis and calvarial mineralizationSeoyeon Bok, Alisha R Yallowitz, Jun Sun, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American Society of Nephrology : JASN|October 30, 2020
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) StudySarah J Schrauben, Haochang Shou, Xiaoming Zhang, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
BMC Neurology|April 10, 2021
Blood flow response to orthostatic challenge identifies signatures of the failure of static cerebral autoregulation in patients with cerebrovascular diseaseClara Gregori-Pla, Rickson C Mesquita, Christopher G Favilla, et al.
Pageof 70